×
News Home

Is Celldex Therapeutics, Inc. (CLDX) Stock a Great Value?

Tuesday, December 15, 2020 10:40 AM | InvestorsObserver Analysts
Is Celldex Therapeutics, Inc. (CLDX) Stock a Great Value?

Celldex Therapeutics, Inc. (CLDX) stock is up 714.48% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CLDX stock a score of 82 out of a possible 100.

That rank is influenced by a short-term technical score of 97. CLDX's rank also includes a long-term technical score of 81. The fundamental score for CLDX is 69. In addition to the average rating from Wall Street analysts, CLDX stock has a mean target price of 26.333. This means analysts expect the stock to gain 46.29% over the next 12 months.

Overall Score - 82
CLDX has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on CLDX!

What's Happening with CLDX Stock Today

Celldex Therapeutics, Inc. (CLDX) stock is lower by -1.32% while the S&P 500 is up 0.55% as of 10:37 AM on Tuesday, Dec 15. CLDX is lower by -$0.24 from the previous closing price of $18.24 on volume of 133,171 shares. Over the past year the S&P 500 has gained 14.92% while CLDX is up 714.48%. CLDX lost -$2.22 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Celldex Therapeutics, Inc. (CLDX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App